# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-027846
Filing Date
2025-07-29
Accepted
2025-07-29 16:58:07
Documents
26
Period of Report
2025-09-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20049997x1_def14a.htm iXBRL | DEF 14A | 1598455
6 | GRAPHIC | logo_roivant02.jpg | GRAPHIC | 34616
7 | GRAPHIC | logo_roivant02x1.jpg | GRAPHIC | 32659
8 | GRAPHIC | ny20049997x1_barchart01.jpg | GRAPHIC | 121807
9 | GRAPHIC | ny20049997x1_barchart02.jpg | GRAPHIC | 129547
10 | GRAPHIC | ny20049997x1_barchart03.jpg | GRAPHIC | 134867
11 | GRAPHIC | ny20049997x1_barchart04.jpg | GRAPHIC | 118865
12 | GRAPHIC | ny20049997x1_image01.jpg | GRAPHIC | 4448
13 | GRAPHIC | ny20049997x1_image02.jpg | GRAPHIC | 4273
14 | GRAPHIC | ny20049997x1_pc01.jpg | GRAPHIC | 748114
15 | GRAPHIC | ny20049997x1_pc02.jpg | GRAPHIC | 584253
| Complete submission text file | 0001140361-25-027846.txt |  | 7179753

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | roiv-20250910.xsd | EX-101.SCH | 3289
3 | INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE | roiv-20250910_def.xml | EX-101.DEF | 1947
4 | INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE | roiv-20250910_lab.xml | EX-101.LAB | 1944
5 | INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE | roiv-20250910_pre.xml | EX-101.PRE | 2231
28 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20049997x1_def14a_htm.xml | XML | 145456

Mailing Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB
Business Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-40782 | Film No.: 251162659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)